Better Therapeutics, Inc. (BTTX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 22.94 Million USD | -54.98% |
| 2021 | 50.95 Million USD | 697.84% |
| 2020 | 6.38 Million USD | 30.85% |
| 2019 | 4.88 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q1 | 12.8 Million USD | -44.17% |
| 2023 Q2 | 11.6 Million USD | -9.4% |
| 2023 Q3 | 10.72 Million USD | -7.6% |
| 2022 Q3 | 28.22 Million USD | -23.94% |
| 2022 Q2 | 37.1 Million USD | -7.91% |
| 2022 Q1 | 40.29 Million USD | -20.93% |
| 2022 FY | 22.94 Million USD | -54.98% |
| 2022 Q4 | 22.94 Million USD | -18.7% |
| 2021 FY | 50.95 Million USD | 697.84% |
| 2021 Q4 | 50.95 Million USD | -11.83% |
| 2021 Q3 | 57.79 Million USD | 494.08% |
| 2021 Q2 | 9.72 Million USD | -83.23% |
| 2021 Q1 | 58.02 Million USD | 908384.72% |
| 2020 Q4 | 6387.00 USD | 0.0% |
| 2020 FY | 6.38 Million USD | 30.85% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 4.88 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| America Great Health | 299.12 Thousand USD | -7569.935% |
| Ampio Pharmaceuticals, Inc. | 5.73 Million USD | -299.983% |
| Aridis Pharmaceuticals, Inc. | 14.69 Million USD | -56.128% |
| Biora Therapeutics, Inc. | 31.21 Million USD | 26.5% |
| Bio-Path Holdings, Inc. | 3.22 Million USD | -612.516% |
| Calithera Biosciences, Inc. | 28.67 Million USD | 19.992% |
| Comera Life Sciences Holdings, Inc. | 3.72 Million USD | -515.57% |
| Gene Biotherapeutics, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | 20.54 Million USD | -11.677% |
| Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | -8.616% |
| Evelo Biosciences, Inc. | 64.44 Million USD | 64.397% |
| Evolutionary Genomics, Inc. | 2.35 Million USD | -874.759% |
| Finch Therapeutics Group, Inc. | 70.99 Million USD | 67.685% |
| Galera Therapeutics, Inc. | 26.14 Million USD | 12.234% |
| Innovation1 Biotech Inc. | 75.99 Thousand USD | -30090.939% |
| Kiromic BioPharma, Inc. | 12.16 Million USD | -88.536% |
| Molecular Templates, Inc. | 35.38 Million USD | 35.158% |
| Navidea Biopharmaceuticals, Inc. | 4.37 Million USD | -424.819% |
| NexImmune, Inc. | 8.59 Million USD | -166.967% |
| Orgenesis Inc. | 14.55 Million USD | -57.662% |
| Panbela Therapeutics, Inc. | 11.8 Million USD | -94.399% |
| Point of Care Nano-Technology, Inc. | 124.64 Thousand USD | -18306.97% |
| PaxMedica, Inc. Common Stock | 5.68 Million USD | -303.897% |
| Scopus BioPharma Inc. | 392.26 Thousand USD | -5748.852% |
| Sorrento Therapeutics, Inc. | 472.84 Million USD | 95.148% |
| Statera Biopharma, Inc. | 21.16 Million USD | -8.377% |
| TRACON Pharmaceuticals, Inc. | 10.1 Million USD | -127.046% |
| Trevena, Inc. | 40.6 Million USD | 43.497% |
| Vaxxinity, Inc. | 44.35 Million USD | 48.272% |
| Vaccinex, Inc. | 3.63 Million USD | -531.865% |
| Vicapsys Life Sciences, Inc. | 39.65 Thousand USD | -57755.053% |
| Viracta Therapeutics, Inc. | 56.69 Million USD | 59.53% |
| ZIVO Bioscience, Inc. | 555.71 Thousand USD | -4028.555% |